D. Shire et al., STRUCTURAL FEATURES OF THE CENTRAL CANNABINOID CB1 RECEPTOR INVOLVED IN THE BINDING OF THE SPECIFIC CB1 ANTAGONIST SR 141716A, The Journal of biological chemistry, 271(12), 1996, pp. 6941-6946
The antagonist SR 141716A has a high specificity for the central CB1 c
annabinoid receptor and negligeable affinity for the peripheral CB2 re
ceptor, making it an excellent tool for probing receptor structure-act
ivity relationships. From binding experiments with mutated CB1 and wit
h chimeric CB1/CB2 receptors we have begun to identify the domains of
CB1 implicated in the recognition of SR 141716A, Receptors were transi
ently expressed in COS-3 cells, and their binding characteristics were
studied with SR 141716A and with CP 55,940, an agonist recognized equ
ally well by the two receptors. The region delineated by the fourth an
d fifth transmembrane helices of CB1 proved to be crucial for high aff
inity binding of SR 141716A. The CB1 and CB2 second extracellular loop
s, e2, were exchanged, modifications that had no effect on SR 141716A
binding in the CB1 variant but that eliminated CP 55,940 binding in bo
th mutants, The replacement of the conserved cysteine residues in e2 o
f CB2 by serine also eliminated CP 55,940 binding, but replacement of
those in CB1 resulted in the sequestration of the mutated receptors in
the cell cytoplasm, The e2 domain thus plays some role in CP 55,940 b
inding but none in SR 141716A recognition, binding of the latter clear
ly implicating residues in the adjoining transmembrane helices.